Urine Hormone Testing for Abnormal Bleeding and Cancer Risk
Part of Cancer, Women’s health & pregnancy clinical trials.
This study measures hormones in urine to understand why some women have abnormal uterine bleeding and whether it increases cancer risk. It may help doctors better predict and prevent uterine cancer in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 35 years old or older
- You have experienced abnormal uterine bleeding (heavier, longer, or more frequent periods than normal)
- You are not currently pregnant and won't become pregnant during the study
- You have not had surgery that removed your uterus or both ovaries
- You have not taken birth control pills, fertility drugs, or hormone replacement therapy in the past 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a risk model to detect endometrial cancer in people with unexplained abnormal uterine bleeding. It aims to find better ways to identify cancer early without relying only on invasive biopsies.
This study is looking at women who have unusual bleeding or bleeding after menopause to find better ways to diagnose reproductive cancers like endometrial cancer. If you are 45 or older and still have your uterus, you may be able to help.
This study tests whether a simple vaginal fluid sample can help detect endometrial cancer (cancer of the uterus lining) or precancerous changes. You'll provide a vaginal specimen alongside your standard medical care, helping researchers develop a non-invasive screening tool.
This study tests a simple, non-invasive method to detect endometrial cancer in women after menopause who have abnormal bleeding. It aims to find cancer early in those at higher risk, such as women with certain genetic conditions or risk factors.
This early-stage study tests medicines that may help control heavy uterine bleeding by changing how blood clots work in the uterus. If you have regular periods and meet the setup rules, you may be asked to provide menstrual tracking and undergo an endometrial (uterine lining) biopsy.
This study checks whether a sample of fluid from the uterus (uterine lavage) can help detect ovarian or fallopian tube cancer. You may join if you are having certain gynecologic surgeries or, in a smaller group, you have a BRCA1/2 mutation.
Hear when a new Uterine Bleeding trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.